Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Peringkat dalam Saham #33378
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Harga Saham
$0.05124204
Kapitalisasi Pasar
$7.78M
Perubahan (1 hari)
0.51%
Perubahan (1 tahun)
-23.73%
Negara
CH
Perdagangan Addex Therapeutics Ltd (ADXN)

Kategori

Riwayat harga saham Addex Therapeutics Ltd (ADXN)
Harga penutupan tertinggi: $0.05 pada 2026-08-01

Harga penutupan terendah: $54.79 pada 2007-05-01
Riwayat harga saham Addex Therapeutics Ltd dari 2007 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -6.77%
2025 5.69%
2024 28.65%
2023 -59.04%
2022 -89.21%
2021 -42.01%
2020 15.05%
2019 -25.63%
2018 1.94%
2017 22.36%
2016 -37.32%
2015 15.45%
2014 -35.66%
2013 -62.43%
2012 68.65%
2011 -41.91%
2010 -59.41%
2009 -21.49%
2008 -3.22%
2007 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$505.24 28.63%
US
$846.09 29.41%
NL
$733.26 6.70%
CH
$1.07K -6.40%
KR
$255.97 13.59%
BE